Stroke prophylaxis in nonvalvular atrial fibrillation<
暂无分享,去创建一个
[1] R. Sacco,et al. Antithrombotic and thrombolytic therapy for ischemic stroke. , 2001, Chest.
[2] R. Tsuyuki,et al. Adequacy of Anticoagulation in Patients with Atrial Fibrillation Coming to a Hospital , 2000, Pharmacotherapy.
[3] L. Kalra,et al. Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness , 2000, BMJ : British Medical Journal.
[4] D. Witter,et al. Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. , 2000, Archives of internal medicine.
[5] E. Berge,et al. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study , 2000, The Lancet.
[6] R. Kronmal,et al. Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. , 2000, Archives of neurology.
[7] J. Hirsh,et al. Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. , 2000, Archives of internal medicine.
[8] F. Madoré,et al. Oral anticoagulant therapy for heart disease: results in actual cardiology practice. , 2000, The Canadian journal of cardiology.
[9] F. McAlister,et al. Why do patients with atrial fibrillation not receive warfarin? , 2000, Archives of internal medicine.
[10] Allen J. Taylor,et al. Can Warfarin Randomized Trials Be Reproduced in ‘Real Life’?: Adherence to Warfarin Guidelines for Intensity of Anticoagulation in a University-Based Warfarin Clinic , 2000, Southern medical journal.
[11] Taylor Aj,et al. Can warfarin randomized trials be reproduced in 'real life'? Adherence to warfarin guidelines for intensity of anticoagulation in a university-based warfarin clinic. , 2000 .
[12] W. Newton,et al. Preventing stroke in patients with atrial fibrillation. , 2000, The Journal of family practice.
[13] R. Hart,et al. Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention , 1999, Annals of Internal Medicine.
[14] D. Leys,et al. Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? , 1999, Heart.
[15] Á. Chamorro,et al. Heparin in acute stroke with atrial fibrillation: clinical relevance of very early treatment. , 1999, Archives of neurology.
[16] David C. Anderson,et al. ATRIAL FIBRILLATION AND STROKE: EPIDEMIOLOGY, PATHOPHYSIOLOGY, AND MANAGEMENT , 1998 .
[17] H. Krumholz,et al. Warfarin use among patients with atrial fibrillation. , 1997, Stroke.
[18] S. Kemp,et al. Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals , 1997, Neurology.
[19] Peter Sandercock,et al. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997, The Lancet.
[20] J. Avorn,et al. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. , 1997, Archives of internal medicine.
[21] Atrial fibrillation follow-up investigation of rhythm management -- the AFFIRM study design. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators. , 1997, The American journal of cardiology.
[22] J. Ansell,et al. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. , 1996, American heart journal.
[23] R B D'Agostino,et al. Stroke severity in atrial fibrillation. The Framingham Study. , 1996, Stroke.
[24] W. J. Hamilton,et al. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.
[25] D. Singer,et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. , 1996, The New England journal of medicine.
[26] R B D'Agostino,et al. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. , 1996, American heart journal.
[27] David C. Anderson,et al. Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation , 1996, Neurology.
[28] L K Gottlieb,et al. Anticoagulation in Atrial Fibrillation: Does Efficacy in Clinical Trials Translate Into Effectiveness in Practice? , 1994 .
[29] E. Hylek,et al. Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin , 1994, Annals of Internal Medicine.
[30] Stroke Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study , 1994, The Lancet.
[31] H. White,et al. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation : stroke prevention in atrial fibrillation II study. Commentary , 1994 .
[32] Eaft Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993, The Lancet.
[33] J. Rothrock,et al. Ischemic stroke in patients with atrial fibrillation , 1993, Neurology.
[34] Leandro Provinciali,et al. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .
[35] J. Howard,et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. , 1993, The New England journal of medicine.
[36] J. Slattery,et al. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project) , 1992, BMJ.
[37] D. Singer. Randomized trials of warfarin for atrial fibrillation. , 1992, The New England journal of medicine.
[38] S M Nazarian,et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.
[39] M Gent,et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. , 1991, Journal of the American College of Cardiology.
[40] Lippincott Williams Wilkins,et al. Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.
[41] Bernard Rosner,et al. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1990, The New England journal of medicine.
[42] Palle Petersen,et al. PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.
[43] R. Asinger,et al. Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. , 1989, Archives of neurology.
[44] P. Wolf,et al. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. , 1987, Archives of internal medicine.